Wednesday’s top brokerage calls: Bharti Airtel, Dabur and Sun Pharma

CLSA on Bharti Airtel, Bharti Airtel share price, Bharti Airtel, brokerage calls, stock market

CLSA on Bharti Airtel | The brokerage said Q2 revenue and earnings before interest, tax, depreciation and amortisation were ahead of estimates and maintained a ‘buy’ rating on the stock.

Morgan Stanley on Dabur, Dabur, dabur share price, brokerage calls, stock market

Morgan Stanley on Dabur | Dabur’s Q2 earnings were ahead of Morgan Stanley’s and consensus estimates, the brokerage said. Morgan Stanley also highlighted that the management sounded bullish on the demand outlook and distribution expansion. It maintained its ‘overweight’ call on the stock.

Morgan Stanley on Sun Pharma, Sun Pharma share price, stock market, brokerage calls

Morgan Stanley on Sun Pharmaceutical Industries | Specialty business ramp-up, balance sheet strengthening and potential Halol remediation are drivers for re-rating for Sun Pharma shares, according to Morgan Stanley. The brokerage also expects the company’s margin to continue to improve going ahead.

CLSA on Dabur, Dabur share price, Dabur, stock market, brokerage calls

CLSA on Dabur | CLSA has cut its FY23 earnings estimate for Dabur by 3 percent to factor in higher tax guidance and near-term pressure on margin. The brokerage has maintained its ‘outperform’ rating on the shares.